Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 99.36
-2.36 (-2.32%)
At close: Jan 23, 2026
NSE:GKSL Revenue
Gujarat Kidney And Super Speciality had revenue of 152.60M INR in the quarter ending June 30, 2025, with 63.47% growth. This brings the company's revenue in the last twelve months to 461.67M. In the fiscal year ending March 31, 2025, Gujarat Kidney And Super Speciality had annual revenue of 402.42M with 742.89% growth.
Revenue (ttm)
461.67M
Revenue Growth
+742.89%
P/S Ratio
17.37
Revenue / Employee
1.37M
Employees
354
Market Cap
8.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 402.42M | 354.68M | 742.89% |
| Mar 31, 2024 | 47.74M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 7.86M | -3.17M | -28.71% |
| Mar 31, 2021 | 11.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Park Medi World | 15.11B |
| Kovai Medical Center and Hospital | 14.78B |
| KMC Speciality Hospitals (India) | 2.64B |
| Asarfi Hospital | 1.47B |
| Unihealth Hospitals | 789.82M |
| Nephro Care India | 676.68M |
| Shanmuga Hospital | 480.16M |
| Maitreya Medicare | 459.99M |